This article is more than 5 years old. Information may no longer be current.
Ortho Clinical Diagnostics collaborates to promote C-reactive protein assay
Click Here to Manage Email Alerts
Ortho Clinical Diagnostics announced an international distribution and co-promotion agreement with Sentinel Diagnostics to provide the CRP Ultra MicroTip Partnership Assay, a wide-range C-reactive protein assay, according to a press release.
“Our MicroTip Partnership Assays program helps us expand our reach in delivering innovative, important new assays to our customers,” Robert Yates, chief operating officer of Ortho, said in the release. “The CRP Ultra Assay helps us deliver this important assay for use on our automated Vitros Systems, helping labs deliver critical test results while increasing operational efficiency.”
The CRP Ultra assay was designed to provide a combination of low-end sensitivity with a wide linear range and extended on-analyzer stability.
The agreement is part of an ongoing MicroTip Partnership Assay program created by Ortho to collaborate with other diagnostics companies. The assay will initially launch in North America, Europe, Africa and the Middle East.
Reference: www.orthoclinicaldiagnostics.com